20 September 2016 - Deborah Wilkes
Archived
GlaxoSmithKline has named Emma Walmsley – currently head of its Consumer Healthcare division – as chief executive officer designate. She will take over from Sir Andrew Witty when he retires on 31 March 2017.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.